C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/14 (2006.01) A61K 31/4709 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2649224
Invented is a method of inhibiting the activity/function of PI3 kinases using thiazolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiazolidinedione derivatives.
L'invention concerne une méthode destinée à inhiber l'activité/fonction des kinases PI3 au moyen de dérivés de thiazolidinedione. L'invention concerne également une méthode de traitement d'un ou plusieurs états pathologiques choisis parmi les troubles auto-immuns, les maladies inflammatoires, les maladies cardiovasculaires, les maladies neurodégénératives, l'allergie, l'asthme, la pancréatite, la défaillance multiviscérale, les maladies rénales, l'agrégation plaquettaire, le cancer, la motilité du sperme, le rejet de transplantation, le rejet de greffe et les lésions pulmonaires, par administration de dérivés de thiazolidinedione.
Adams Nicholas D.
Darcy Michael Gerard
Knight Steven David
Schmidt Stanley J.
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Thiazolidinedione derivatives as pi3 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidinedione derivatives as pi3 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidinedione derivatives as pi3 kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1558906